Crispr Therapeutics
Price & Volume
Stats
See moreOpen | $50.89 |
Previous Close | $50.63 |
Day Range | $49.36-$50.89 |
52W Range | $44.12-$78.48 |
Market Cap | $5.2B |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $4.1M |
Revenue Growth (YoY) | 68.6% |
Gross Profit (12 Mos) | -$478.7M |
Diluted EPS | -$6.17 |
News
See moreYahoo Finance • 3 days ago
Cathie Wood buys $22.8 million of surging tech stock
Yahoo Finance • 4 days ago
3 Reasons to Buy CRISPR Therapeutics Stock
Yahoo Finance • 7 days ago
CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026?
Yahoo Finance • 9 days ago
CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
About
CEO | Dr. Samarth Kulkarni Ph.D. |
Address | Baarerstrasse 14, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 393 |